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Valid Study 
• Identify the conditions to be detected 
• Train judges to reliably identify the conditions 
• Develop a uniform and valid screening protocol 
• Administer the protocol to a representative 
sample 
• Wean the screening protocol to the set of 
simplest, inexpensive , effective tools. 
• Identify a referral  mechanism to access  
treatment for those positively screened 
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Modified Clinical Technique 
1954 Orinda Study 
True State  
Opt/Ophtal Judgment 
Postive Negative  
MCT 
Refer 209 37 
Positive Predictive 
Value 
246 (85%) 
Don’t 
Refer 
22 917 
Negative 
Predictive Value 
939 (98%) 
Sensitivity 
231(90%) 
Specificity 
954 (96%) 
Prevalence  
1185 (24%) 
Estimate prevalence based on demographics 
Cluster sample – Stratified 
p(Normal vision) = 0.889 + 1.97 ( % families in poverty) -1.58 (% Hispanic) 
Washington County 
PUCO Screening Results 
Darker areas have highest probability 
of positive results 
Oregon and  
Southern Washington 
Bayes Rule 
Estimate PPV from multiple tests 
• Combine PPV from individual tests in the 
battery.   
• Repeat screenings each year 
 
 
Caucasian Asian 
n Reps 0.044 0.185 
1 0.52 0.84 
2 0.77 0.97 
3 0.89 1.00 
4 0.95 1.00 
5 0.97 1.00 
6 0.99 1.00 
Probability of 1 or more  
Positive results 
Efficacy of Screening 
Phi Coefficient 
• Measure each component of the screening battery 
• Range -1.00 to +1.00 
• Identify components where Phi > .75 
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Summary 
• Identify specific treatable conditions and tests that determine 
criteria for the “Truth”.   
• Identify a set of screening tests that will likely identify people 
with one or more of the conditions 
• Random Cluster sampling to get a representative sample of 
the target population 
• Stratified sampling to insure estimation of prevalence of 
treatable vision conditions across diverse populations 
• Estimate positive and negative predictive values for the 
screening tests relative to the identified conditions. 
• Identify a referral path to appropriate treatment for positive 
screenings  
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